Driving Innovation,
Delivering Value
Ryvu Therapeutics is a clinical-stage drug discovery and development company focused on novel oncology therapies that address emerging targets in oncology. Internally discovered pipeline candidates at Ryvu use diverse therapeutic mechanisms driven by emerging knowledge of cancer biology, including small molecules and antibody-drug conjugates directed at kinases, synthetic lethality, and immuno-oncology targets.
Press releases
12.06.2025
News
Ryvu Therapeutics Presents Data on RVU120 at the European Hematology Association Congress 2025
Read more29.05.2025
News
Ryvu Therapeutics announces promotion of Justyna Żółtek to the Management Board
Read more
Reports
26.06.2025
Current Stock reports
Current Report ESPI 23/2025
Shareholders controlling at least 5% of the votes at the General Shareholders Meeting of Ryvu Therapeutics S.A. convened on June 26th, 2025
Read more26.06.2025
Current Stock reports
Current Report ESPI 22/2025
Resolutions adopted by the General Shareholders Meeting of Ryvu Therapeutics S.A.
Read more
Publications
- pdf file
Phase I/II trial of RVU120, a CDK8/CDK19 inhibitor in patients with relapsed/refractory metastatic or advanced solid tumors
Download - pdf file
Discovery of novel MTA-cooperative PRMT5 preclinical candidate as targeted therapeutics for MTAP-deleted cancers
Download - pdf file
Discovery of WRN inhibitors as targeted therapy in the treatment of microsatellite unstable (MSI-H) tumors
Download - pdf file
Exploring Synthetic Lethality and Novel Drug Combinations in Patient-Derived Cells
Download
- pdf file
Preclinical candidate RVU305, an MTA-cooperative, brain-permeable PRMT5 inhibitor, shows activity in MTAP-deleted tumors resistant to immune checkpoint treatment
Download - pdf file
Discovery of novel synthetic lethal targets for effective and safe colorectal cancer therapies
Download
Stock info
Key Stock Details

Media Pack
Download company assets
- zip file
Company logo pack
Download - zip file
Management board
Download - zip file
Labs
Download - zip file
Ryvu building
Download - zip file
About Ryvu
Download
Contact
for Investors & Media
At Ryvu Therapeutics, we are dedicated to maintaining transparent and open communication with our media partners and investors. If you have any questions or require further information, please don’t hesitate to contact us at [email protected].
